Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-induced NF-κB activation

Ozlem Equils, Alan Shapiro, Zeynep Madak, Chunren Liu, Daning Lu

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-induced NF-κB activation'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science